TrademarkDir
Serial #79256173
LIVE

Serial Number

79256173

Owner

GW Research Limited

Attorney

Michael T. Olsen

Filing Date

Feb 1, 2019

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

Serial #79256173 Trademark

Serial Number: 79256173 • Registration: 5964103

Serial #79256173 is a trademark filed by GW Research Limited on February 1, 2019. The trademark is classified under Class 5 (Pharmaceuticals), Class 31 (Natural Agricultural Products). The application is currently registered and active.

Owner Contact Info

GW Research Limited (77 trademarks)

Sovereign House,

Entity Type: 98

Jazz Pharmaceuticals Research UK Limited (46 trademarks)

Building 730,

Entity Type: 98

Trademark Details

Filing Date

February 1, 2019

Registration Date

January 21, 2020

Published for Opposition

November 5, 2019

Goods & Services

[ Agricultural and horticultural products, namely, agricultural seeds, fruit seeds, natural plants and flowers; seeds for planting; flowers; live plants ]

Pharmaceutical [ and veterinary ] preparations and substances; pharmaceutical preparations and substances for the treatment of epilepsy [; herbs for medicinal purposes; medicinal herbs; medicinal oils; medicinal infusions; pure extracts of medicinal plants and herbs; foodstuffs for medicinal purposes; herb teas for medicinal purposes; all of the aforesaid for the treatment of neurological diseases and conditions ]

Filing History

NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
Feb 24, 2026 NA71
REGISTERED - PARTIAL SEC 71 ACCEPTED
Feb 24, 2026 71.P
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
Feb 18, 2026 EROP
PROOF OF USE INTERIM ACTION ISSUED
Feb 12, 2026 PUMI
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
Feb 6, 2026 EROP
OFFICE ACTION ISSUED POU1
Jan 8, 2026 PUM1
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Jan 8, 2026 APRE
CHANGE OF NAME/ADDRESS REC'D FROM IB
Dec 11, 2025 ADCH
TEAS SECTION 71 RECEIVED
Dec 2, 2025 ES71
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Jan 21, 2025 REM3
NEW REPRESENTATIVE AT IB RECEIVED
Nov 20, 2021 NREP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Sep 15, 2021 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sep 15, 2021 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Sep 15, 2021 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sep 15, 2021 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Sep 15, 2021 COAR
FINAL DECISION TRANSACTION PROCESSED BY IB
May 22, 2020 FINO
FINAL DISPOSITION NOTICE SENT TO IB
May 4, 2020 FICS
FINAL DISPOSITION PROCESSED
May 4, 2020 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Apr 21, 2020 FICR
REGISTERED-PRINCIPAL REGISTER
Jan 21, 2020 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 5, 2019 NPUB
PUBLISHED FOR OPPOSITION
Nov 5, 2019 PUBO
NOTIFICATION PROCESSED BY IB
Nov 1, 2019 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Oct 16, 2019 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Oct 16, 2019 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 16, 2019 NONP
ASSIGNED TO LIE
Sep 30, 2019 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 23, 2019 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 20, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 20, 2019 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 20, 2019 TROA
REFUSAL PROCESSED BY IB
May 25, 2019 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
May 7, 2019 RFCS
REFUSAL PROCESSED BY MPU
May 7, 2019 RFRR
APPLICATION FILING RECEIPT MAILED
Apr 16, 2019 MAFR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Apr 14, 2019 RFCR
NON-FINAL ACTION WRITTEN
Apr 13, 2019 CNRT
ASSIGNED TO EXAMINER
Apr 13, 2019 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 12, 2019 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Apr 11, 2019 REPR

Related Trademarks

More from this Owner

EPIFOS

EPIFOS

EPIDYOLEX

EPIDYOLEX

LIVING WITH

LIVING WITH

LIVING WITH

LIVING WITH

IMPACT INNOVATIVE MEDICAL PERSPECTIVES, ADVANCING CANNABIDIOL TREATMENT logo

IMPACT INNOVATIVE MEDICAL PERSPECTIVES, ADVANCING CANNABIDIOL TREATMENT

IMPACT INNOVATIVE MEDICAL PERSPECTIVES, ADVANCING CANNABIDIOL TREATMENT logo

IMPACT INNOVATIVE MEDICAL PERSPECTIVES, ADVANCING CANNABIDIOL TREATMENT